s6y

4 EPIRUS Biopharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities

Filed
Period
Accession number
0001104659-15-066201

Documents

  1. 4 4
  2. EX-24 EX-24

On sec.gov